BIO Financial Facts
Research and development expense: 52.17MProvision for income taxes: -8.85M
See Full Income Statement
Common stock: 2K
Finished goods: 300.07M
See Full Balance Sheet
Bio-Rad Laboratories, Inc. (BIO) Earnings
|
Expand Research on BIO
| Next EPS Date | 4/25/24 | EPS Growth Rate | -30.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | -7.0% |
| Average % Move 1-Wk after EPS | -5.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/11/21 |  |
Q420 | $4.01 | $3.29 | +$0.72 | $789.8M | $686.8M | N/A |  | | Details |
| 2/10/22 | |
Q421 | $3.21 | $2.87 | +$0.34 | $732.8M | $727.48M | N/A | | | Details |
| 2/16/23 | Q422 | $3.31 | $3.47 | -$0.16 | $730.3M | $747.26M | N/A | | | Details | |
| 4/29/21 | |
Q121 | $5.21 | $3.00 | +$2.21 | $726.8M | $660.98M | N/A | | | Details |
| 7/29/21 | |
Q221 | $3.54 | $2.66 | +$0.88 | $715.9M | $631.78M | N/A | | | Details |
| 10/28/21 | |
Q321 | $3.71 | $2.44 | +$1.27 | $715.2M | $661.87M | N/A | | | Details |
| 4/28/22 | |
Q122 | $4.94 | $3.40 | +$1.54 | $700M | $675.1M | N/A | | | Details |
| 7/28/22 | Q222 | $3.38 | $2.80 | +$0.58 | $691.1M | $682.62M | N/A | | | Details |
